phenylalanine has been researched along with glucagon-like peptide 1 in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 5 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hall, WL; Millward, DJ; Morgan, LM; Rogers, PJ | 1 |
Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 1 |
Ball, AJ; Flatt, PR; McClenaghan, NH | 1 |
Clark, R; Inoue, T; Nagakura, T; Saeki, T; Shinoda, M; Sugaya, Y; Tanaka, I; Yamamoto, E; Yamazaki, K; Yasuda, N | 1 |
Duffy, NA; Flatt, PR; Gault, VA; Green, BD; Irwin, N; McKillop, AM; O'Harte, FP | 1 |
Bell, PM; Cuthbertson, J; O'Harte, FP; Patterson, S | 1 |
Eto, Y; Kawanabe, H; Kitahara, Y; Miura, K; Ogawa, S; Yasuda, R | 1 |
Chen, M; Guo, Z; Hao, J; Houze, J; Lin, DC; Lopez, E; Luo, J; Ma, Z; Nguyen, K; Rulifson, IC; Tian, B; Tian, L; Tran, T; Wang, Y; Zhang, Y | 1 |
Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K | 1 |
Bojsen-Møller, KN; Dirksen, C; Holm, L; Holst, JJ; Kristiansen, VB; Madsbad, S; Madsen, JL; Martinussen, C; Rehfeld, JF; Reitelseder, S; Svane, MS; van Hall, G | 1 |
Feinle-Bisset, C; Fitzgerald, PCE; Herbillon, B; Horowitz, M; Manoliu, B; Steinert, RE | 1 |
Alaa, A; Amin, A; Frampton, J; Franco-Becker, G; Li, JV; Liu, Z; Murphy, KG; Norton, M | 1 |
Harada, K; Osuga, Y; Tsuboi, T | 1 |
Masiques, NE; Müller, M; Navarro, M; Roura, E; Tilbrook, A; van Barneveld, R; Xu, C | 1 |
Hara, H; Hira, T; Kohda, N; Noguchi, H | 1 |
5 trial(s) available for phenylalanine and glucagon-like peptide 1
Article | Year |
---|---|
Physiological mechanisms mediating aspartame-induced satiety.
Topics: Adult; Appetite; Aspartame; Aspartic Acid; Blood Glucose; Cholecystokinin; Cross-Over Studies; Diet; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Insulin; Male; Peptide Fragments; Phenylalanine; Protein Precursors; Satiety Response; Sweetening Agents | 2003 |
Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes.
Topics: Aged; Blood Glucose; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Nateglinide; Phenylalanine; Postprandial Period; Treatment Outcome | 2011 |
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult | 2014 |
Effects of L-Phenylalanine on Energy Intake and Glycaemia-Impacts on Appetite Perceptions, Gastrointestinal Hormones and Gastric Emptying in Healthy Males.
Topics: Appetite; Beverages; Blood Glucose; Cholecystokinin; Double-Blind Method; Energy Intake; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Peptide YY; Phenylalanine; Young Adult | 2020 |
Differential effects of L- and D-phenylalanine on pancreatic and gastrointestinal hormone release in humans: A randomized crossover study.
Topics: Appetite; Blood Glucose; Cross-Over Studies; Energy Intake; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon-Like Peptide 1; Humans; Insulin; Phenylalanine; Postprandial Period | 2021 |
10 other study(ies) available for phenylalanine and glucagon-like peptide 1
Article | Year |
---|---|
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine | 2003 |
Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
Topics: Cell Line; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclohexanes; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Nateglinide; Phenylalanine; Potassium Channels; Protein Kinase C; Stimulation, Chemical; Sulfonylurea Compounds; Tetradecanoylphorbol Acetate | 2006 |
Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats.
Topics: Animals; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glyburide; Imidazoles; Insulin; Male; Mice; Mice, Inbred C57BL; Nateglinide; Phenylalanine; Protease Inhibitors; Pyridazines; Rats; Rats, Wistar; Tosyl Compounds | 2007 |
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
Topics: Animals; Blood Glucose; Cell Line; Cyclohexanes; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Nateglinide; Peptide Fragments; Phenylalanine | 2007 |
Nateglinide stimulates glucagon-like peptide-1 release by human intestinal L cells via a K(ATP) channel-independent mechanism.
Topics: Animals; Cell Line; Cyclohexanes; Glucagon-Like Peptide 1; Humans; Intestinal Mucosa; Intestines; Male; Nateglinide; Phenylalanine; Potassium Channels; Rats; Rats, Wistar | 2011 |
Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Nateglinide; Peptides; Phenylalanine; Pyrazines; Sitagliptin Phosphate; Specific Pathogen-Free Organisms; Triazoles; Venoms | 2013 |
Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
Topics: Adult; Anastomosis, Roux-en-Y; Blood Glucose; Caseins; Cholecystokinin; Cross-Sectional Studies; Dietary Proteins; Female; Gastrectomy; Gastric Bypass; Gastric Emptying; Gastrointestinal Hormones; Ghrelin; Glucagon-Like Peptide 1; Glucose; Glycerol; Humans; Insulin; Intestinal Absorption; Male; Middle Aged; Peptide YY; Phenylalanine; Postprandial Period | 2019 |
Identification of a regulatory pathway of L-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells.
Topics: Animals; Calcium; Cell Line; Enteroendocrine Cells; Gastrointestinal Tract; Glucagon-Like Peptide 1; GTP-Binding Protein alpha Subunits, Gq-G11; Membrane Transport Proteins; Mice; Phenylalanine; Receptors, Calcium-Sensing; Receptors, G-Protein-Coupled; Sodium; Taste | 2022 |
Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
Topics: Animals; Cholecystokinin; Glucagon-Like Peptide 1; Glucose; Incretins; Leucine; Lysine; Male; Phenylalanine; Satiation; Swine | 2023 |
Synergistic enhancement of glucagon-like peptide-1 release by γ-aminobutyric acid and L-phenylalanine in enteroendocrine cells-searching active ingredients in a water extract of corn zein protein.
Topics: Animals; Chromatography, Liquid; Enteroendocrine Cells; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; Mice; Phenylalanine; Proteins; Tandem Mass Spectrometry; Zea mays; Zein | 2023 |